Top compounds associated with response to LRTM2


Feature Type Standardized
Nominal ANOVA
mRNA CCT018159 GDSC1000 pan-cancer AAC -0.065 0.05
mRNA Rapamycin gCSI pan-cancer AAC -0.1 0.05
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.064 0.05
mRNA erastin CTRPv2 pan-cancer AAC 0.067 0.05
mRNA GW-405833 CTRPv2 pan-cancer AAC 0.066 0.05
mRNA PD-0325901 gCSI pan-cancer AAC -0.095 0.05
mRNA Bicalutamide GDSC1000 pan-cancer AAC -0.063 0.05
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.066 0.05
mRNA STF-62247 GDSC1000 pan-cancer AAC 0.061 0.05
mRNA Merck60 CTRPv2 pan-cancer AAC 0.056 0.06
Download CSV